drugset / Trial / NCT06890286
A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this clinical study is to evaluate the pharmacokinetics and safety between single oral administration of BR3006 and co-administration of BR3006A, BR3006B and BR3006C in healthy adult volunteers under fasting conditions
Timeline
- Start
- 2024-12-01
- Primary completion
- 2025-01-03
- Completion
- 2025-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR3006 | Unknown | — | Oral |
| Comparator | BR3006A | Unknown | — | Oral |
| Comparator | BR3006B | Unknown | — | Oral |
| Comparator | BR3006C | Unknown | — | Oral |